Trial Profile
Pre-Operative PARPi and Irradiation (POPI) in Women With an Incomplete Response to Neo-Adjuvant Chemotherapy for Breast Cancer
Status:
Suspended
Phase of Trial:
Phase I
Latest Information Update: 24 Aug 2023
Price :
$35
*
At a glance
- Drugs Veliparib (Primary)
- Indications Adenocarcinoma; Advanced breast cancer; Early breast cancer
- Focus Adverse reactions
- 20 Aug 2023 Planned End Date changed from 31 Dec 2023 to 31 Dec 2024.
- 20 Aug 2023 Planned primary completion date changed from 31 Dec 2022 to 31 Dec 2023.
- 06 Jun 2022 Planned End Date changed from 31 Jan 2023 to 31 Dec 2023.